Search Results

Tool could eventually identify which patients will benefit most from immune checkpoint inhibitors.

UCLA study finds treatment is safe, helps more patients reach surgery and reveals new insights into the tumor’s immune response.

Blood-based testing may help predict immunotherapy response and personalize breast cancer treatment.

Multidisciplinary team at Kilpauk Medical College manages life-threatening thrombotic thrombocytopenic purpura during pregnancy.

New study shows IgG1 plasma cells help predict which patients respond to PD-1 cancer therapy.

High sucralose intake linked to weaker immune response in cancer therapy, University of Pittsburgh researchers report.